CoChat

The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis

Maslej, Marta M., Bolker, Benjamin M., Russell, Marley J., Eaton, Keifer, Durisko, Zachary, Hollon, Steven D., Swanson, G. Marie, Thomson Jr., J. Anderson, Mulsant, Benoit H., Andrews, Paul W. · 2017 · Psychotherapy and Psychosomatics

The DOI matches its Crossref record; 95 of the 96 references it cites were found in a registry or an index.

Abstract

Background: Antidepressants (ADs) are commonly prescribed medications, but their long-term health effects are debated. ADs disrupt multiple adaptive processes regulated by evolutionarily ancient biochemicals, potentially increasing mortality. However, many ADs also have anticlotting properties that can be efficacious in treating cardiovascular disease. We conducted a meta-analysis assessing the effects of ADs on all-cause mortality and cardiovascular events in general-population and cardiovascular-patient samples. Methods: Two reviewers independently assessed articles from PubMed, EMBASE, and Google Scholar for AD-related mortality controlling for depression and other comorbidities. From these articles, we extracted information about cardiovascular events, cardiovascular risk status, and AD class. We conducted mixed-effect meta-analyses testing sample type and AD class as moderators of all-cause mortality and new cardiovascular events. Results: Seventeen studies met our search criteria. Sample type consistently moderated health risks. In general-population samples, AD use increased the risks of mortality (HR = 1.33, 95% CI: 1.14-1.55) and new cardiovascular events (HR = 1.14, 95% CI: 1.08-1.21). In cardiovascular patients, AD use did not significantly affect risks. AD class also moderated mortality, but the serotonin reuptake inhibitors were not significantly different from tricyclic ADs (TCAs) (HR = 1.10, 95% CI: 0.93-1.31, p = 0.27). Only “other ADs” were differentiable from TCAs (HR = 1.35, 95% CI: 1.08-1.69). Mortality risk estimates increased when we analyzed the subset of studies controlling for premedication depression, suggesting the absence of confounding by indication. Conclusions: The results support the hypothesis that ADs are harmful in the general population but less harmful in cardiovascular patients.

Overview

Integrity signals

Registry

Crossref · 10.1159/000477940

Cites

95 of 95 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 95 references

Cited by

Metadata

Authors
Maslej, M. M., Bolker, B. M., Russell, M. J., Eaton, K., Durisko, Z., Hollon, S. D., Swanson, G. M., Thomson Jr., J. A., Mulsant, B. H., & Andrews, P. W.
Affiliations
  • McMaster University (CA)
  • Vanderbilt University (US)
  • Hamad bin Khalifa University (QA)
  • Centre for Addiction and Mental Health (CA)
Venue
Psychotherapy and Psychosomatics
Publisher
S. Karger AG
Published
2017
Volume
86
Issue
5
Pages
268-282
ISSN
  • 0033-3190 (ISSN-L)
  • 1423-0348
OpenAlex
W2755406504
Cited by
98
References
96
Citations by year
2026: 3 · 2025: 7 · 2024: 10 · 2023: 10 · 2022: 12 · 2021: 15 · 2020: 6 · 2019: 16 · 2018: 17 · 2017: 2
FWCI
1.58
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Psychotherapy and Psychosomatics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Centre for Addiction and Mental Health
  • Universiteit Maastricht
  • University of California, San Francisco
  • Luonnontieteiden ja Tekniikan Tutkimuksen Toimikunta
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
antidepressants, all-cause mortality, cardiovascular events, pre-existing cardiovascular disease, tricyclic antidepressants, serotonin reuptake inhibitors, confounding by indication, depression, cardiovascular risk, adverse drug reactions
MeSH terms
Antidepressive Agents, Tricyclic, Cardiovascular Diseases, Depressive Disorder, Humans, Mortality, Risk Factors, Comorbidity, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.